Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
608studies shown
Showing 1-12 of 608
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

This study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.

In France
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT06887192

ML-007C-MA for Schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.

In France
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Australia, in France, .... It is testing KarXT for manic episodes in bipolarity type I.

In France
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06585787

KarXT for Schizophrenia

This study is recruiting in the United States, in France, in Belgium, .... It is testing KarXT for Schizophrenia.

In France
SchizophreniaOtherFrom 55 Years to 90 Years
Countries
United States, France, Belgium, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07140913

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in France, in Argentina, .... It is testing KarXT for manic episodes in bipolarity type I, including participants taking lithium, valproate, or lamotrigine.

In France
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Argentina, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.

In France
SchizophreniaOtherFrom 5 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.

In France
SchizophreniaOtherFrom 55 Years to 95 Years
Countries
United States, France, Brazil, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.